Alembic Pharmaceuticals Q2 Results
- BSE: 533573
- NSE: APLLTD
- ISIN: INE901L01018
- Sector: Biotechnology & Drugs
BSE
1,096.95
55.15 (5.29%)
55.15 (5.29%)Volume5.05 K
Updated: Mon 25 Nov, 2024 | 15:29:20
NSE
1,093.251.35 (4.93%)
51.35 (4.93%)Volume1.59 L
Updated: Mon 25 Nov, 2024 | 15:43:33
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1,647.98 Cr.(5.52%)
- Operating Profit₹181.62 Cr.(8.24%)
- Profit After Tax₹153.40 Cr.(14.16%)
- Operating Margin11.02%(24.94%)
Note: Comparison is on YoY basis
Quarterly - Alembic Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,647.98 | 1,486.15 | -% | 1,594.93 | -% |
| Selling/ General/ Admin Expenses Total | 391.47 | 348.17 | -% | 346.99 | -% |
| Depreciation/ Amortization | 70.51 | 66.18 | -% | 67.56 | -% |
| Other Operating Expenses Total | 588.13 | 525.78 | -% | 578.26 | -% |
| Total Operating Expense | 1,466.36 | 1,353.65 | -% | 1,454.24 | -% |
| Operating Income | 181.62 | 132.50 | -% | 140.69 | -% |
| Net Income Before Taxes | 180.42 | 129.78 | -% | 135.15 | -% |
| Net Income | 153.40 | 120.60 | -% | 136.56 | -% |
| Diluted Normalized EPS | 7.24 | 6.14 | -% | 6.95 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST